At the Pharma Leadership & Innovation (PLI) Conclave 2025 in Mumbai, Dr Pratibha Pilgaonkar, Founder and MD of Rubicon Research, discussed the significance of talent development and leadership in driving industry growth. She outlined the need for a structured approach that integrates education, mentorship, experience, and continuous learning.
Building on this, she highlighted how Rubicon Research has consistently prioritised identifying and nurturing future leaders while maintaining a strong focus on quality and patient care. The company’s growth, both in India and globally, has been driven by sustained investment in talent development. From its inception, the organisation has actively worked towards creating a pipeline of skilled professionals.
Expanding on the company’s approach, she emphasised the importance of engaging professionals from diverse backgrounds. Rubicon Research has incorporated experienced retired professionals into its workforce, recognising the value of their expertise, while also creating opportunities for fresh graduates through experiential learning initiatives.
The Rubicon Academy has played a central role in offering structured training programmes for both students and employees, ensuring continuous skill enhancement. To further support work force development, the company has implemented a strong performance appraisal system. This includes regular feedback, mentorship opportunities, and skill development exercises designed to encourage continuous learning. Additionally, collaboration with external agencies has strengthened its workforce capabilities, providing access to global best practices.
Dr Pilgaonkar also underscored that leadership in the pharma sector requires adaptability, resilience, and a proactive approach to fostering a growth mindset. She stressed that sustained investment in leadership development is essential for securing the industry’s future.